Dapagliflozin and Urinary Tract Infection Risk in Type 2 Diabetes: A Comprehensive Critical Review of Mechanistic, Randomized, and Real-World Evidence. Tropical Journal of Pharmaceutical and Life Sciences, v. 13, n. 5, p. 53–68, 30 Oct.2026.